Based on this, we do not state that the candidates that did not pass through the additional screens are not valid targets in RB1-deficient cells, we only state that the candidates that passed through all filters would more likely kill RB1-deficient cells in highly heterogeneous tumor cells. Here, RB1 is linked to neoplasm.